摘要
目的:
1、揭示定喘穴埋针对哮喘大鼠模型信号转导子和转录激活子(STAT6)蛋白含量,嗜酸性细胞特异性趋化因子(Eotaxin)蛋白含量及其mRNA表达,以及支气管肺泡灌洗液(BALF)和血清中白细胞介素-4(IL-4)、白细胞介素-5(IL-5)含量及嗜酸性粒细胞(Eos)数的影响,探索定喘穴埋针治疗支气管哮喘的作用机制,从而为临床治疗哮喘提供新的治疗方法和理论依据。
2、揭示定喘穴埋针对各组大鼠不同时点(60m、90m和120m)肺组织中原癌基因蛋白质(c-fos)表达的影响,以明确定喘穴埋针在支气管哮喘治疗中的神经免疫作用途径及机制,进而丰富定喘穴埋针治疗支气管哮喘的科学内涵。
方法:
选取健康4-6周龄Wistar大鼠136只,采用卵白蛋白(OVA)激发致敏建立哮喘模型。实验一:大鼠随机分为正常对照组8只,哮喘模型组8只,地塞米松组8只,埋针组8只,穴位注射组8只。实验二:大鼠随机分为正常对照组24只、哮喘模型组24只、埋针组24只、埋针并损毁孤束核(NTS)组24只,每组间又随机分为60m、90m和120m三个时点,每个时点大鼠8只。
光镜观察肺组织病理形态学的变化,采用免疫组化法和原位杂交法检测哮喘大鼠模型STAT6、Eotaxin蛋白及其mRNA表达,酶联免疫吸附试验法(ELISA法)检测BALF及血清中IL-4、IL-5含量,瑞氏(Wright)染色法测定BALF中WBC数,Eos数及分类数。采用免疫组化法检测大鼠正常对照组、哮喘模型组、埋针组、埋针并损毁孤束核(NTS)组三个时点(60m、90m、120m)c-fos蛋白的表达。
结果:
1、造模成功后,经干预治疗,埋针组、地塞米松组和穴位注射组与哮喘模型组比较,大鼠激发后6-10min症状明显减轻,引喘潜伏期明显延长,跌倒率显著降低,经统计学处理,有显著性差异(P<0.01);埋针组与地塞米松组相近,无显著性差异(P>0.05);埋针组与穴位注射组比较有显著性差异,具有统计学意义(P<0.01)。穴位注射组与地塞米松组比较有显著性差异,具有统计学意义(P<0.01)。
2、哮喘大鼠模型组STAT6蛋白,Eotaxin蛋白及其mRNA表达明显高于正常对照组,经统计学处理,有显著性差异(P<0.01);埋针组、地塞米松组和穴位注射组STAT6蛋白、Eotaxin蛋白含量低于模型组,其mRNA表达明显弱于模型组,经统计学处理,有显著性差异(P<0.01);埋针组与地塞米松组相近,无显著性差异(P>0.05);埋针组与穴位注射组比较有显著性差异,具有统计学意义(P<0.01)。穴位注射组与地塞米松组比较有显著性差异,具有统计学意义(P<0.01)。
3、哮喘模型组BALF及血清中IL-4、IL-5含量明显高于正常对照组,经统计学处理,有显著性差异(P<0.01);埋针组、地塞米松组和穴位注射组BALF及血清IL-4,IL-5含量明显低于哮喘模型组,有显著性差异(P<0.01);埋针组与地塞米松组相近,无显著性差异(P>0.05);埋针组与穴位注射组比较有显著性差异,具有统计学意义(P<0.01)。穴位注射组与地塞米松组比较有显著性差异,具有统计学意义(P<0.01)。
4、哮喘模型组BALF中Eos绝对值及Eos%较正常对照组显著升高,经统计学处理,有显著性差异(P<0.01);埋针组、地塞米松组和穴位注射组BALF中Eos绝对值及Eos%明显低于模型组,有显著性差异(P<0.01);埋针组与地塞米松组相近,无显著性差异(P>0.05);埋针组与穴位注射组比较有显著性差异,具有统计学意义(P<0.01)。穴位注射组与地塞米松组比较有显著性差异,具有统计学意义(P<0.01)。
5、哮喘模型组大鼠肺脏中c-fos表达明显高于正常对照组,经统计学比较,有显著性差异(P<0.01);埋针组大鼠肺脏中c-fos表达明显弱于模型组,以120分钟组最为明显,经统计学比较,有显著性差异(P<0.01);埋针并损毁孤束核(NTS)组大鼠肺脏中c-fos表达弱于模型组,以120分钟组最为明显,经统计学比较,有显著性差异(P<0.01);埋针组哮喘大鼠模型肺脏中c-fos表达弱于埋针并损毁孤束核(NTS)组,以120分钟组最为明显,经统计学比较,有显著性差异(P<0.01)。
结论:
1定喘穴埋针可以明显减轻大鼠哮喘症状发作程度。
2定喘穴埋针通过降低哮喘大鼠模型STAT6、Eotaxin蛋白含量以及下调STAT6mRNA、EotaxinmRNA在气道上皮细胞的表达,降低哮喘大鼠BALF及血清中IL-4、IL-5含量,降低BALF中Eos数,来干预气道炎症,从而达到治疗支气管哮喘的目的。
3定喘穴埋针可能通过干预哮喘炎性信息传入的低位整合中枢孤束核(NTS),从而减弱哮喘大鼠模型肺脏中c-fos蛋白的表达,这可能是定喘穴埋针实现其对神经免疫调节作用机制的途径之一。
Purpose:
1 In order to reveal the effets of method with needle–embedding therapy in Dingchuan point to the asthma rat model STAT6 protein content、Eotaxin protein content and their mRNA and the contents of IL-4、IL-5 and Eos numbers in the serum and BALF,inquiry into the function mechanisms of with needle-embedding therapy in Dingchuan point to bronchial asthma ,provide new treatment methods and theoretical basis for clinical treatment.
2 In order to reveal the influence of method with needle-embedding therapy in Dingchuan point of treating the asthma rat model of c-fos protein content in the lung tissues at different points in time( 60m、90m and 120m),reveal the role of the channels and mechanisms with needle-embedding therapy in Dingchuan point to bronchial asthma , so as to improve the scientific connotation of bronchial asthma in Dingchuan point.
Methods:
Selecting 136 healthy 4-6 week-old Wistar rats were as targets in this experiment,which were randomly divideded into groups. Sensitized with OVA to stimulate the rats to establish the asthma model. 1 Experiment: 40 Wistar rats were randomly divideded into 5 groups, control group(8)、asthma rat model group (8)、dexamethason group (8)、needle– embedding therapy group(8) and acupoint injection group (8).2 Experiment: 96 Wistar rats were randomly divideded into 4 groups. control group(24)、asthma rat model group (24)、needle–embedding therapy group(24)、spoiling NTS group(24),were randomly divided into 60m, 90m and 120m 3 point in time in each group.
Observe the pathological changes in lung tissues with light microscope.Adopting immunohistochemistry method and hybrid diz-ation in situ method to examine the expression of asthma rat models of STAT6、Eotaxin protein and their mRNA; Adopting ELISA (enzyme linked immunosorbentassay) to examine the contents IL-4、IL-5 in BALF and serum of asthma rats;The Wright staining examine the WBC number、classification and Eos number in the BALF. Immunohistochemistry method examine expression of the c-fos in the lung tissues asthma rats.
Results:
1 After the success of modeling, needle-embedding therapy group, dexamethasone group and acupoint injection group, compared with the asthma model group, significantly reduced the symptoms in rats,latent period of asthma was significantly prolonged, falls rate was significantly reduced. Statistically, there are significant differences in them(P<0.01), needle–embe -dding therapy group and dexamethasone group are similar, there was no significant difference between them(P>0.05). There are significant differences between needle-embedding therapy group and acupoint injection group (P <0.01). There are significant differences between acupoint injection groupand dexamethasone group(P <0.01).
2 The expression of STAT6 protein、Eotaxin protein and their mRNA were significantly higher in asthmatic rat model group than the control group (P<0.01).STAT6 protein、Eotaxin protein contents were lower in needle embe -dding therapy group、dexamethasone group and acupoint injection group than the model group (P<0.01), theirs mRNA expression was significantly weaker than the model group, Statistically, there were significant differences in them (P<0.01). Needle-embedding therapy group and dexamethasone group were similar, there was no significant difference between them(P>0.05). There are significant differences between needle-embedding therapy group and acupoint injection group (P <0.01). There are significant differences between acupoint injection groupand dexamethasone group(P <0.01).
3 In bronchoalveolar lavage fluid (BALF) and serum levels of IL-4、IL-5 in asthma model group, were significantly higher than the normal control group(P<0.01).The contents of IL-4、IL-5 in BALF and serum were signify -cantly lower than the asthma model group in needle-embedding therapy group、dexamethasone group and acupoint injection group(P<0.01). There are significant differences between needle-embedding therapy group and acupoint injection group (P <0.01). There are significant differences between acupoint injection groupand dexamethasone group(P <0.01).
4 The absolute value of Eos in BALF and Eos% was higher in asthmatic model group than the normal control group(P<0.01). The absolute value of BALF in the Eos and Eos% was significantly lower in needle-embedding therapy group、dexamethasone group and acupoint injection group than the model group(P<0.01). Needle-embedding therapy group and dexamethasone group are similar, there is no significant difference between them(P>0.05). There are significant differences between needle-embedding therapy group and acupoint injection group (P <0.01). There are significant differences between acupoint injection groupand dexamethasone group(P <0.01).
5 In the lungs of asthma model rats c-fos expression was significantly higher than the normal control group(P<0.01).C-fos expression of the lungs of rats in needle-embedding therapy group was significantly weaker than the model group (P<0.01). The 120 minutes group is most obvious in them.C-fos expression of NTS rats in the lungs is weaker than the model group(P<0.01). The expression of c-fos proteins in needle-embedding therapy group was weaker than the spoiling nucleus (NTS) group(P<0.01). The 120 minutes group is most obvious in them.
Conclusions:
1 Needle-embedding therapy in Dingchuan point can significantly reduce the level of rats with symptoms of asthma attack.
2 By reducing the contents of the STAT6 and Eotaxin protein in the asthma rat models,downing the expression of the STAT6 mRNA and EotaxinmRNA in airway epithelial cells,reducing the levels of BALF and serum IL-4, IL-5 to asthmatic rats, reducing the number of Eos in BALF,interfere with airway inflammation, so as to achieve the purpose of treatment of bronchial asthma.
3 Needle-embedding therapy in Dingchuan point may interfere with asthma,through inflammatory information passed by the low integration of the central nucleus of solitary tract, reduced c-fos proteins expression in lung tissiues of rats,this may be the one of the ways to achieve its effects on neural mechanisms of immune regulation.
引文
[1]中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南[J](支气管哮喘的定义、诊断、治疗及教育和管理方案).中华结核和呼吸杂志,2003,26(3):132-138
[2]美国国立卫生研究院心肺血液研究所.全球哮喘防治的创议[R].首都儿科研究所哮喘防治与教育中心译
[3]杨秉辉.现代内科学进展[M].上海科学技术文献出版社,2005:177-184
[4]Global Burden of Asthma,Masoli Metal.Global Initiative for Asthma (GI -NA),2004
[5]叶建红,江建国,刘永莉等.电针不同时段对大鼠中枢CAMP含量的影响[J].放射免疫学杂志,2002,15(1);14-15
[6]董自斌.套管埋线治疗坐骨神经痛320例[J].中国针灸,1994,14(4)
[7]刘雨星,梁繁荣,宋开源等,不同针灸疗法对AA大鼠炎症局部皮温、肿胀度和痛阈影响的比较研究[J].四川中医,2001,19(12);6-7
[8]Bochner BS,Undem BJ,LichtensteinLM.Immunol ogicala spects of allergic asthma.Annu Rev lmmuno1.1994 12:295-335
[9]王山泽,叶曜芬,罗文侗.支气管哮喘发病机理和防治进展[J].济南:山东科技出版社,1992,179-197
[10]Young RP,shcrp PA,Lyhch JR,et al.Confirmation of genetic linkage between atopic IgE responses and chromosome 11q 13.J Med Genct,1992,29:236
[11]陈育智,赵京,陈坤华等.全国十省市螨皮肤过敏原情况调查[J].实用诊断与治疗杂志,1994,8(哮喘专刊):3
[12]Sunyer J, Spix C, Quencl P, et al. Urban air producotion and emergency admissions for asthma in four Earopean cities: the APHEA project. Thorax, 1997,52(9):760
[13]Brian WP S,Kent E P,kathleen E,et al.Second-hand smoke is an adjuvant for T hccper-2 responses in a murine model of allergy. J Immunol,1997 159(12):6169
[14]WoodruffPG,FahyJV.Asthma:prevalence pathogenesis prospects for novel thera -pies[J].JAMA2001,286(4):395-398
[15]Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3 [J] Science , 2003, 299 (5609) :1057-1061
[16]陈季强,卞如濂等.支气管哮喘发病机制和抗哮喘新药研究进展[J]. 2003, 32 (4):271
[17]齐继成,世界抗哮喘药物研究开发最新进展[J].中国医药技术与市场, 2007, 7 (2):32
[18]孔祥裕,钟淑清等.哮喘免疫治疗的研究进展[J].国际医药卫生导报. 2007, 13 (16):158
[19]李岩,朱海英等.76例支气管哮喘缓解期应用表面激素的临床观察[J].中国社区医生,2006,6:13
[20]HavingaW.Riskof asthma [J].Lancet, 2001, 357(9252): 313-314
[21]Abramson MJ,Puy RM,Weiner JM.Is allergen immunotherapy effective in asthma Ametaanalysis of randomized controled trials[J].Am J Respir Crit Care Med, 1995, 151: 969-974
[22]Malling HJ.Immunotherapy as an effective tool in allergy treatment [J]. Allergy, 1998,53(5):461-472
[23]Bousquet J,Lockey R,Malling HJ,et al.Allergen immunotherapy: therap -eutic vaccines for allergic diseases.A WHO position paper[J].J Allergy Clin Immunol, 1998, 102(3):558-562
[24]Coyle AJ,Wagner K,Bertrand C,et al.Central role of immunoglobulin (Ig)E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibitionbya non-anaphylactogenicanti-IgE antibody[J]. J Exp Med, 1996, 183(4): 1303-1310
[25]Holgate ST,Come J,Jardieu P,et al.Treatment of allergic airways disease with anti-IgE[J]. Allergy, 1998,53(1):83-88
[26]Heusser CH,Wagner K,Bews JP,et al.Demon-stration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction,lung function and infammation[J].Int Arch Allergy Immunol, 1997,113(1-3):231-235
[27]BusseWW,RosenwasserLJ.Mechanismsofasthma[J].JAllergy Clin Immunol, 2003, 111 (l):799-804
[28]Behera AK,Kumar M,Lockey RF,et al. Aden–ovirus -mediated interfere onγgene therapy for allergic asthma:involvement of interleukin 12 and STAT4 signaling[J]. Hum Gene Ther,2002,13(9):1697-1709
[29]Tanak H,Nagai H,Maeda Y.Effect of anti-IL-4 and antiIL-5 antibodieson allergicairway hyperresponsiveness in mice[J].Life Science. 1998, 62(1): 169-174
[30]Shardonofsky FR,Venzor J 3rd,Barrios R,et al.Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the res-piratory tract in a murine model of asthma [J] Jallergy Clin Immunol, 1999, 104(1): 215-221
[31]SimonHU,YousefiS,Schranz C,et al.Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia[J].J Immunol, 1997, 158 (8): 3902-3908
[32]Del pozo V,Rojo M,Rubio ML,et al.Gene therapy with galectin-3 inhibits bronchial obstruction and inflammation in antigenchallenged rats through interleukin-5 genedownregulation[J].Am J Respir Crit CareMed, 2002, 166(5): 732-737
[33]Pretolani M,Goldman M.IL-10:a potentialtherapy for allergic inflame mation [J]. ImmunolToday,1997,18(2):277-280
[34]Ob JW,Seroogy CM,Meyer EH,et al.CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation[J].J Allergy ClinI mmunol,2002,110(3):460-468
[35]胡俊华,吴健民,崔天盆等.STAT-6基因3'非翻译区G2964A位点多态性与湖北汉族哮喘人群及IgE的相关性研究[J].临床检验杂志,2005,23:9-11
[36]吴波,李亚斐,熊鸿燕等.哮喘人群STAT6基因多态性的研究[J].免疫学杂志, 2006,22:308-310
[37]曾佳,雄瑛等.信号转导子和转录激活子6基因与支气管哮喘的研究进展[J].国际呼吸杂志.2007,27(17)
[38]Stolzenberger S,Haake A,Duschl A.Inhibition of STAT6 by anin trace llul -arly delivered peptide. J Immunobiol, 2001, 204: 29-30
[39]李新平,张学光.RNA干扰技术在免疫学研究中的应用[J].现代免疫学,2005,25:174-176
[40]黄文林,朱孝峰.信号转导[M].北京:人民卫生出版社,2005:185-192
[41]Behera AK,Kumar M,Lochey RF,et al.Adenovirus mediated interferon gamma gene therapy for allergic asthma:involvement of interleukin 4 and STAT6 signaling. Hum Gene Ther,2002,13:1697-1709
[42]Karrogawa Y, Lee HJ, Johnston JA, el al. Cutting edge: a conditionally active formof STAT6 can mimie certain effects of IL-4.J Immunol, 1998, 161: 1074-1077
[43]Wurster AL,Tanaka T,Grusby MJ.The biology of Stat4 and Stat6. Oncogene, 2002, 19:2577-2584
[44]Hayase H,Ishizu A,Ikeda H,et al.Aberrant gene expression by CD25+CD4+ immunoregulatory T cells in autoimmune prone rats carrying the human T cell leukemia virus type-I gene.LntLmmunol,2005,17:677-684
[45]Trifilieff A, EI-Hasim A, Corteling R. Abrogation of lung inflammation in sensitized STAT6-deficient mice is dependent on the allergen inhalation procedure. British J Pharmacol,2000,130:1581-1588
[46]Cooney RN.Suppressors of cytokine signaling SOCS: inhibitors of the JAK/STAT pathway. Shock, 2002, 17: 83-90
[47]Jose Z, Maria DR, Fernando S. Proteolyticregulation of activated STAT6 by calpains1.J Immunol,2005,2:2844-2848
[48]Lisa H,Susan J.Regulation of STAT signalling by proteolytic proce -ssing.Eur J Biochem,2004,271:4613-4620
[49]Matsukuras,StellatoC,Plitt JR, et al. Activation of eotaxin gene transcription by NF–KB and STAT6 in Human airway epithelialcells. J lmmunol,1999,163:6876-6883
[50]AkihoH,BlennerhassettP, DengY, etal.Role of IL-4, IL-13 and STAT6 in inflam -mation induced hypercontractility of murine smooth muscle cells.Am J Physiol Gas Trointest Liver Physiol2002, 282:G226-232
[51]李静,趋化因子Eotaxin及其受体与支气管哮喘[J].国际儿科学杂志.2006,33(3):406-408
[52]Wong KH, Negishi H, Adashi EY.Expression, hormonal regulation, and cyclic variation of chcmokincs in the rat ovary : key determinants of the intraovarian residence of of representatives of the white blood cell serics.Endocrinology 2002;143(3):784-91
[53]崔德健,曾泽戎.支气管哮喘豚鼠模型支气管肺组织血管细胞黏附分子和eotaxin的表达和调控[J].中华结核和呼吸杂志,2002:25(11):655-60
[54]曾泽戎,崔德健.嗜酸粒细胞特异性趋化因子eotaxin[J].国外医学:呼吸系统分册,2003,23(2):66-99
[55]Zimmermann N, Daugherty BL, StarkJM,et al.Molecular analysis of CCR-3 events in eosinophilic ce11s.J Immunol 2000;164(2):1055-64
[56]付杰伟,陈平,向学东.嗜酸细胞趋化因子在哮喘、慢性支气管炎患者诱导痰中的表达及其与气道炎症的关系[J].中华结核和呼吸杂志2002,25(1):29-32
[57]Mattoli S, Stacey MA, Sun G,etaL.Eotaxin expression and eosinophilic inflamation -in asthma .Biochem Biophys Res Commun 1997;236(2)299-301
[58]YingS, MengQ, Zeibecoglouk, et al. Eosino Philchemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocytechemoattractan protein-3(MCP-3), and MCP-4,and C-Cchemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatis[J]. Journal of Immunology , 1999, 163(11):6321-6329
[59]ZeibecoglouK,YingS,Yamada T , etal.Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from Patienis with atopic as compared with atopic and nonatopic controlsubjects[J].Journal of Allergy and Clinical Immun -ology, 1999, 103(l):99-106
[60]Heath H,QinS,RaoP,etal, Chemokine receptor usage by human eosino Phils.The importance of CCR3 demonstrated using an antagonistic monoclonal antibody[J]. Journal of Clinical Investigation, 1997, 99(2):178-184
[61]Bandeira-MeloC,PhoofoloM,Weller PF Extranuclear lipid bodies , elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leuko tri -ene C4 Production in eosinoPhils and basophils[J].Journal of Biological Chemistry,2001, 276(25):22779-22787
[62]OliveiraSH , LiraS , Martinez-AC , etal.Increased responsiveness of murine eosinophils to MIP-1beta(CCL4) and TCA-3(CCLI) is mediated by their specifie receptors CCR5 and CCR8[J].Journal of Leukocyte Biology, 2002, 71(6): 1019-1025
[63]Ponath Po.Qin SX.Ringler DJ, etal, Cloning of the human eosinophil chemo attractant, eotaxin(J) Clin invest, 1996, 97:604-612
[64]李凝,许以平.CCL趋化因子和支气管哮喘[J].国外医学,呼吸系统分册,2001,21(3):118-121
[65]MouldAW. MatthaeiKl, YoungIG, etal. Relationship between interleukins and eotaxin in regulating blood and tissue eosinophilia in mice(J)JClin Invest, 1997,99:1064-1071
[66]Hanazawa T.Antuni JD.Kharitonov.SA, etal.Intranasal administration ofEotaxin increase nasal eosinophils and nitrieoxide in patients with allergic rhinitis(J)J Allergy Clin Immunol,2000,56-64
[67]G Arcia-Zepeda F.A.Rothenberg ME.Weremowicz S etal Genomic organ iza -tion,complete sequence and chromosomal location of the gene for man eotaxin(SCYALL),an eosnophil-specific CC chemoline(J).Gememic,1997,41(3): 471 -476
[68]Bandeira MelolC,HerbstA,Weller PF. Eotaxins contributing to the diversity of eosinophil recruitment and activation[J].Am JRespir Cell Mol Bio,l 2001, 24(6): 653
[69]Lamkhioued B,Abdelilah SG,Hamid Q, et al The CCR3 receptor is involved in eosinophil differentiation and is upregulated by Th1 Cytok ines in CD34+progenitor cells[J] J Immunol 2003, 170(1): 537
[70]MosmannTR,Coffman RL.THI and TH2 cells:dieffernt pattenrs of lymphokine secretion lead to different functional properties.Annu Immunol, 1989; 7:145-173
[71]Rajeev Venkayya , Maggie Lma, Madeleine Willkom etal.TheTh2 Lymphocyte ProductsIL-4andIL-13 Repidly Induce Airway Hyper responsiveness Through Direct Eeffets on Resident Aiwary Cell. Am.J.Respire Cell Mol.Biol, 2002; 26:202
[72]Robinson DS , Hamid Q , YingS , etal.Predominant TH2-like bornchoalveolar T-lymlphocyte population in atopic asthma.NEnglJMed, 1992;326:298-304
[73]LiL , Xia Y,NguyenA , LaiYH , FengL , MosmannTR , LoD.Eff ects of TH2 Cytokineson chemokine-expression in the lung:IL-13 potently induces eoxatin express -ion by airway, epithelial cells.Jlmmunol, 1999; 162: 2477-2487
[74]Leckie MJ, ten Brinke A, KhanJ etal.Eeffets of an interlekin-5 blocking mono Clonal antibody on eosinophils , airway hyper-responsiveness , and the asthmatic response.Lancet, 2000;365:2144-2148
[75]Bryan SA, 0 Conneor BJ, Matti S etal, Eeffcts of recombinant human Interl -eukin-12 on eosinphils, airway hyprresponsiveness, and the late asthma Resp -onse, Lancet, 2000;356:2149-2153
[76]BarnesPJ.Cytokines as mediators of chronic asthma. Am J Respir Crit CareMed.1994Nov;150(2):542-9
[77]周云桂,黄绍良,李树浓等.小儿哮喘发病中DC23、IFN和IgE的作用及其意义[J].中国免疫学杂志,1997,13(6):381-383
[78]Parronchi P,Tiri A,Maccia D,etal.Noncognate contact dependent B cell activation can promote IL-4 dependent in vitro human IgE synthesis. J Immunol. 1990, 15; 144 (6): 2102-8
[79]中华医学会呼吸病学分会,支气管哮喘防治指南[J].中华结核和呼吸杂志,1997;205,261
[80]BarnesPJ.Cytokines as mediators of chronic asthma. Am J Respir Crit Care Med.1994Nov;150(5Pt2):542-9
[81]CorryDB,Kherdmand F. Induction and regulation of the IgE response. Nature. 1999Nov25;402(6760SuppI):B18-23
[82]王志华.IL-4的研究及其进展[M].国外医学·免疫学分册,1989,(3):113-116.
[83]Daher SESantos LM,Sole D,etal.Interleukin4 and soluble CD23 serum levels in asthmatic atopic children. JInvest Allegrol Clin Immunol, 1995, 5:251-254
[84]WalkerC,BauerW,Braun RK etal Activated T ceels and cytolines in bronchoalveolar lavages from patienis with various lung diseases associated with eosinophilia. AmJ Respir Crit Care Med 1994, 150:1038-1048
[85]文昭明.呼吸系统变态反应疾病诊断治疗学[M].第1版.中国协和医科大学出版社,2002;2
[86]余柏泉.细胞和分子免疫学[M].第二版,科学出版社,2001
[87]Grrossman J.One airway ,one disease[J], Chest, 1997; 111:11-16
[88]中华医学会呼吸病学分会,支气管哮喘防治指南[J].中华结核和呼吸杂志,1997;205,261
[89]Ogasawara H ,Asakura K,Saito H,et al.Role of CD4-positive T cells in the pathogenesis of nasal allergy in themurine mode[J].Int Arch Allergy Immunol , 1999, 118: 37-43
[90]Sehmi R, Wood LJ, Watson R, et al. Allergy-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects[J]. Clin Invest, 1997,100: 2466-2475
[91]Lefort J, Bachelet CM, Leduc D, et al. Effect of antigen provocation of IL-S transgenic mice on eosinophil mobilization and bronchial hyperres ponsiveness[J]. Allergy Clin Immunol, 1996,97:788-799.
[92]Matsumoto K, Saito II the role of eosinophilis in asthma: Sarastroor the Queen of the night[J] In Arch Allergy Immunol, 2001, 125:290-296
[93]Yamaguci Y, Suda T, Ohta S, et al. Analysis of the survival of mature human eosinophils, inerleukin-5 prevents apoptosis in mature human eosin ophils[J]. Blood, 1991, 178:2542-2547
[94]赖克方,王长征,郭先健等.氟美松对嗜酸性粒细胞凋亡的作用及其机制[J].中华内科学杂志,2000,39(2):111-114
[95]吴银根,徐重明,李培成等.咳喘落对哮喘模型豚鼠外周血IL-5含量影响的实验研究[J].中医研究,1998,11(l):15
[96]Monzies Gow A,Robinson DS, Eosinophils eosinophilis Cytokines (interl -eukin5),and antieosinophilic therapy in asthma,Curr Opin Med, 2002 : 8:33-38
[97]Dent LA, Strath M,Mellor AL,et a1,Eosinophilia in Ttansgenic Mice Expre -ssing Interleu KinS,J Eep Med,1990,172:1425
[98]Inserra P, Zhang Z, Ardestani SK et al, Modulationof cytokine production bydehydroepiandrosterone (DHEA)plus melatonin (MLT) supplementation of old mice.Proc Soc Exp Biol Med. 1998 May;218(1):76-82
[99]Sterzl I, Hampl R, Hill M, Hrda P, Matucha P. Immunomodulatory cytokines inhuman seminal plasma correlate with immunomodulatory steroids. Steroids. 2003Oct; 68(9):725-731
[100]Unluhizarci K, Kelestimur F, Guven M, Bayram F, Colak R .The value of lowdose (1microg) ACTH stimulation test in the investigation of non-classic adrenalhyperplasia due to llbeta-hydroxylase deficiency.Exp Clin Endocrinol Diabetes.2002 Nov; 110(8): 381-385
[101]Boudarene M, Legros JJ, Timsit-Berthier M, Study of the stress response: role of anxiety, cortisol and DHEAs .Encephale. 2002 Mar-Apr;28(2):139-146
[102]Finset A, Overlie I, et al. Holte A.Musculo-skeletal pain, psycholo gicaldis -tress,andhormonesduring the menopausal transition. Psychoneuro endocri nology.2004Jan;29(1):49-64
[103]Oka H, Negoro H, Sugino Y, et al. Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment Hinyokika Kiyo. 2003 Sep;49(9):521-525
[104]Onat AYazici M, Can G et al, Evidence for a complex risk profile in obesepos tmenopausal Turkish women with hypertriglyceridaemia and elevated apol ipo protein B. Clin Sci (Lond). 2004 Ju1;107(1):97-104
[105]Wills-kap M,Luyimbazi J,Xu X,et al. Interleukin-13:central mediator of allergic asthma.Seience, 1998, 282:2258-2261
[106]Wills-Karp M, Luyimbazi J, Xu X, et al. Interleukin -13:central mediator of allergic asthma. Science, 1998, 282: 2258-2261
[107]Gleich GJ.Mechanisms of eosinophil-associated inflammation[J]. JAll -ergy Clin Immunol ,2000, 105(4):651-663
[108]杨伟康,刘翱,陈宇英等.一氧化氮及一氧化氮酶在哮喘大鼠气道高反应中的作用[J].中国临床康复,2004,8(36):8234-5
[109]刘晓湘,方秀斌.神经生长因子对实验性哮喘豚鼠降钙素基因相关肽的调节作用[J].中国临床康复,2004,8(24):5020-1
[110]SehmiR,BaatjesAJ,DenburgJA.HemoPoietic progenitor cell sand hemop oie -tic factors:Potential targets for treatment of allergic inflame matory diseases[J].Curr Drug Targets Inflamm Allergy,2003 , 2:271-278
[111]Blau HM,Brazleton TR,Weimann JM.The evolving concept of a stem cell:entity or function[J].Cell, 2001, 105:829-841
[112]ShenH,OByrnePM, EilisR,et al.The effects of intranasal budesonide on allergen induced Production of interleukin-5 and eotaxin, airways, blood and Bonemarrow eosinophilia, and eosinophil progenitor expansion in sensitized mice[J].AmJRespir Crit Care Med, 2002, 166(2):146-153
[113]PalframanRT, Collins PD , Williams TJ , etal.Eotaxin induces a rapid releaseofEosinophils and their progenitors from the bone marrow[J].Blood, 1998, 91: 2240-2248
[114]Sehmi R,Dorman S Baatjes A,etal.Allergen-induced fluctuation in CC chemokinereceptor 3 expression on bone marrow CD34+cells from asthmatic subjects:significance for mobilization of haemopoietic progenitor cells in allergic inflammation[J]. Immunology, 2003, 109(4):536-546
[115]Justice JP, BorchersMT, Crosby JR, et al Ablation of eosinophils leads to a reduction of allergen induced pulmonary pathology[ J]. AM J Physiol Lung Cell Mol Physiol 2003, 284(1):L169
[116]Yamamoto K, Takanashi S, Hasegawa Y, et al Eotaxin level in induced sputum is increased in patients with brochial asthma and in smokers. Respiration, 2003, 70(6 ):600
[117]Li D, Wang D, Griffiths-Johnson DA, et al Eotaxin protein and gene expre -ssion in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. EurRespir[J],1997:10(9):1 946
[118]Janknecht R. Regulation of the c-fos promoter[J].Immunobiolog 1995, 193: 137-141
[119]Beveren CV, Stracten FV, Curran T, et al. Analysis of FBJ-MuSV provious and c-fos (mouse) gene reveals that viral and cellular fos gene products hate different carboxy termini[J]. Cell, 1983, 32:1241-1245
[120]Morgan JI, Curran T. Stimulus transcription coupling in neurons:role of cellular immediate-early genes[J]. TIPS,1989,12:459-462
[121]Morgan JI, Cohen DR, Hempstead JI, et al. Mapping patterns of c-fos expression in the central nervous system after seizure[J]. Sci en -ce,1987,237:192-197
[122]Almendral JM, Sommer D, Macdonald-Bravo H, et al. Complexity of the early genetic response to growth factors inmouse fibroblasts[J]. Mol Cell Biol, 1988, 8:2140-2148
[123]Murphy TH, Worley PF, Baraban JM. L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes[J]. Neuron, 1991,7(4): 625-635
[124]Murphy TH, Worley PF, Baraban JM. L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes[J]. Neuron, 1991,7(4): 625-635
[125]ShengM, CreenbergME. The regulation and function of c-fos and other immediate early genes in the nervous system[J]. Neuron, 1990 , 4(4): 477-485
[126]Terasawa K,Okazaki K,Nishida E.Regulation of c-Fos and Fra-1 by the MEK5- ERK5 pathway.Genes Cells 2003;8(3):263-273 25
[127]SAGAR S M,SHARP F R. Early response genes as markers of neuronal activity and growth factor action[J]. Adv Neurol,1993,59:273-284
[128]崔红生,赵兰才.武维屏从肝辨治支气管哮喘经验撷要[J].中国医药学报,1999,14(2):49-51
[129]刘玉山,张爱华,王玉民.射干麻黄汤加味治疗小儿哮喘[J].河北中医.2001,23(6):4
[130]曲文华,孙善辉.清热化痰佐以补肾温阳治疗热哮36例[J].山东中医杂志.1996,15(2):62
[131]印会河主编.中医基础理论[M].上海科技出版社,1984:101
[132]滕修胜.关于以证论痰的思考[J].中国中医基础医学杂志,1996;2(5):50--51
[133]张占伟,王春玲,王鹏等.温阳化痰法在治疗哮喘中的应用[J].中医药研究,2000,16(8):55-57
[134]洪广祥.全程温法治疗哮病之我见[J].中国医药学报,2003.18(5):306-308
[135]吴银根,尹良胜教授.中医药治疗哮喘经验[J].上海中医药大学学报,2006,(20)4:62-63
[136]周仲瑛.哮喘杂谈[J].江苏中医.2000,21(18):15
[137]欧正武.哮喘伏痰新识[J].湖南中医药学报.1998,18(4):25
[138]方永奇,曹建宏,方春亮.从温胆汤的方证看痰证实质[J].中国中医基础医学杂志,1998;4(1):43-45
[139]王九林.痰饮的概念及其成因[J].中国中医基础医学杂志,1998;4(3):47-48
[140]滕修胜.痰概念的演变及内涵[J].中国中医基础医学杂志,1997;3(3):49-50
[141]梁瑛,姚天樵,张蔚等.哮喘与慢性支气管炎气道炎症的临床病理对比性研究[J].中华结核和呼吸杂志1998;21(11):668-671
[142]梁瑛,姚天樵,张蔚,等.哮喘与慢性支气管炎气道炎症的临床病理对比性研究[J].中华结核和呼吸杂志1998;21(11):668-671
[143]辛晓峰.支气管哮喘与气道重塑[M].国外医学呼吸系统分册, 1998;18 (2): 63-65,68
[144]张艰.哮喘气道平滑肌增生的意义及机制[M].国外医学呼吸系统分册, 1996; 16(2):70-72
[145]李小兵,林昌松,骆怡然等.心脑血管病痰证患者免疫功能特点初探[J].中国中医基础医学杂志,1997;(6):50-52
[146]方永奇.痰证病人心血管功能及肺功能的变化特点[M].中医痰病研究与临床.北京:中国中医药出版社,2005:99-101
[147]方永奇,曹建宏,方春亮.从温胆汤的方证看痰实质[J].中国中医基础医学杂志,1998;4(1):43-45
[148]王燕,刘艳艳,杨永清,崔健美,王培育.王宇等针灸治疗支气管哮喘的实验研究进展[J].甘肃中医, 2006, 19( 5): 40
[149]杨永清,陈汉平,王瑞珍等.针刺对哮喘患者外周血活化T淋巴细胞与嗜酸性粒细胞的影响[J] .上海针灸杂志, 1995, 14(2): 58
[150]周荣林.联合穴位脱敏治疗变态反应性鼻炎伴发哮喘149例疗效分析[J] .中国中西医结合杂志, 1997, 17(10): 589
[151]陈良良.足三里穴位免疫疗法防治过敏性哮喘临床及实验研究[J] .中国中西医结合杂志, 2006, 16(12): 709
[152]马淑兰,杨永清,崔龙萍等.针刺血清对高嗜酸性粒细胞血症大鼠外周血嗜酸粒细胞数目的影响[J] .针刺研究, 2002, 27(2): 145
[153]倪伟.穴位注射卡介苗多糖核酸治疗266例哮喘的临床研究[J].中国针灸,2001, 21(11): 647
[154]王钜,潘忠,李士怡.针刺对支气管哮喘学及白三烯D4介质的影响[J].中国针灸, 1996, 16(12): 648
[155]马建吟,陆珊华,孙爱民.激光针疗改善过敏性豚鼠支气管平滑肌功能的实验研究[J] .江苏中医, 2000, 21(9): 42
[156]康晓娥,卓玉翠,赵福气等,化脓灸对支气管哮喘发作期血浆中白三烯C4的影响[J].湖南中医杂志, 2000, 16( 3); 33
[157]杨永清,陈汉平,王瑞珍等.针刺对哮喘患者外周血活化T淋巴细胞与嗜酸性粒细胞的影响[J] .上海针灸杂志, 1995, 14(2): 58
[158]陈良良.足三里穴位免疫疗法防治过敏性哮喘临床及实验研究[J] .中国中西医结合杂志, 1996, 16(12): 709
[159]张琳,穴位埋线对哮喘大鼠THl/TH2的影响[J] .贵阳中医学院学报, 2008,30(3): 46
[160]马晓凡,赵粹英,吴焕淦,等.静脉回输艾灸血清培养的肿瘤浸润淋巴细胞对荷瘤小鼠T细胞亚群的影响[J].针灸临床杂志, 2002, 18(11)∶47-48
[161]马晓凡,赵粹英,李祖剑等.艾灸血清体外对小鼠IL-4淋巴瘤细胞作用的实验研究[J].中医药学刊, 2003, 21(11)∶1949-1950
[162]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J] .中国针灸, 2000, 20(1): 33
[163]宣丽华,徐福,张舒雁.穴位贴敷加穴位注射防治支气管哮喘的临床研究[J].中国针灸, 2002, 22(7): 441
[164]沈利华,吴萍玲,邱潮林.穴位注射卡介菌多糖核酸对支气管哮喘免疫调节效应的观察与机理探讨[J] .河北中医, 2000, 22(12): 888
[165]胡志光,尹钢林.针刺对支气管哮喘患者T细胞亚群和IL-4的影响[ J] .中国针灸, 1999, 19(2): 111
[166]裴建,陈汉平,赵粹英等.“艾灸血清”对免疫活性细胞功能的影响[J].上海针灸杂志,1999, 18(1)∶38-40
[167]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影响[J] .中国针灸, 2000, 20(1): 33
[168]倪伟.穴位注射卡介苗多糖核酸治疗266例哮喘的临床研究[J].中国针灸,2001, 21(11): 647
[169]黄铁军,张吉,詹秀丽.电针对哮喘豚鼠血及肺泡灌洗液中肿瘤坏死因子、内皮素水平的影响[J] .针刺研究, 1999, 24(4): 300
[170]刘鑫,戴爱国,周继鹏.针刺对哮喘豚鼠肺内嗜酸细胞凋亡及Fos表达的影响[J] .上海针灸杂志, 2003, 22(7): 3
[171]韩艾,针刺对支气管哮喘患者细胞免疫功能的影响[J],针灸临床杂志,2000, 16( 4): 53-54
[172]赖新生.针刺对实验性过敏性哮喘豚鼠血浆及肺支气管组织内环核苷酸含量的影响[J] .针灸临床杂志, 1997, 13(3): 24
[173]李俊雄.自血混合丙种球蛋白穴注对哮喘豚鼠血浆皮质醇和核苷酸的影响[ J] .中国针灸, 1999, 19(2): 121
[174]杜雪松,王鹂.穴位注射治疗支气管哮喘60例[J] .辽宁中医杂志, 2002,29(7): 431
[175]杨君军,赖新生.天灸疗法治疗支气管哮喘的疗效及机理研究[J] .吉林中医药, 2003, 23(4): 7
[176]张文彭.宣肺健脾益肾针刺法对支气管哮喘患者肺功能与心率变异性即刻效应的影响[J] .中国中医基础医学杂志, 2004, 10(9): 47
[177]沈虹,胡大文,唐纯志等.穴位贴敷对支气管哮喘患者血浆SP和VIP含量的影响[J] .河南中医, 2002, 22(2): 20
[178]老昌辉.自血混合丙球穴注治疗哮喘的临床观察[J] .中国针灸, 1995,15(6):5
[179]何扬子.激光灸治疗支气管哮喘的机理探讨[J].中国针灸,1996,16(12):7
[180]李俊雄.自血混合丙种球蛋白穴注对哮喘豚鼠血浆皮质醇和核苷酸的影响[J] .中国针灸, 1999, 19(2): 121
[181]何扬子.CO2激光灸对哮喘患者肺通气功能的作用[J] .中国针灸, 1995,15(3): 15
[182]何扬子,梁增芹.CO2激光穴位照射治疗支气管哮喘临床观察[J].中国针灸,1994, 14(1): 13
[183]于雪峰,倪力强,乔世举等.中药穴位贴敷对哮喘患者肺功能的影响[J] .中国中医药信息杂志, 2003, 10(9): 72
[184]于雯,杨慎峭,吕玉玲等.火针对哮喘患者肺功能、IgE的影响及机制探讨[J] .四川中医, 2004, 22(12): 9
[185]王永兴,应延风,郭耿仁.曲安缩松穴位注射对哮喘患者肺功能改善作用[J].现代中西医结合杂志, 2001, 10(2): 95
[186]张文彭,宣肺健脾益肾针刺法对不同程度支气管哮喘患者心率变异性与肺功能的影响[J].Acupuncture Research, 2007, 32:1
[187]蔡志红,董宇翔,刘放等.针刺“清喘穴”即刻止喘多中心对照研究[J].中国针灸,2005,25(6):383-386
[188]张智龙,吉学群,薛莉等.针刺治疗支气管哮喘急性发作期临床观察[J].中国针灸,2005,25(3):158-160
[189]万文蓉,温阳利气法针灸治疗哮喘30例临床观察[J].中国针灸, 2001, 21 (11):649-650
[190]程健生,针刺鱼际穴治疗急性哮喘发作[J].中国针灸,2001,21(9):547
[191]蒋向东,针刺翳风治疗哮喘急性发作60例[J].中国针灸,2002,22
[192]米建平,刘炳权,符文彬等,天灸疗法防治支气管哮喘181例疗效观察[J].新中医,2005,37(2):61-62
[193]李硅,壮医药线点灸疗法治疗肺虚哮喘临床效果观察[J].中国针灸,2005,25(3):181-183
[194]陆波,张晓芸,许冉等.艾灶灸治疗哮喘的体会[J].中国临床康复.2002,6(9):1353
[195]刘明清,黄启嵩,尤斌等,化脓灸治疗支气管哮喘的临床疗效观察[J].中国针灸,2002,22(8):537-539
[196]洪建云.化脓灸治疗支气管哮喘临床研究[J].针灸临床杂志, 2005, 21 (8):35
[197]陈铭,蔡宗敏,卢希玲等,节气灸与支气管哮喘肺功能变化关系初探[J].中国针灸,2000,(3):155-156
[198]卢金玲,黄秋芳,杨彩珍等,穴位注射结合超短波治疗儿童哮喘130例[J].内蒙古中医药, 2008,5:25
[199]仝斌,穴位注射治疗支气管哮喘临床观察[J].中国中医急症2007,16:6
[200]雷励,穿山龙注射液穴位注射治疗重症支气管哮喘临床观察[J].中国中医急症,2005,14(5):419,424
[201]秦建领,陈可劲,叶枫等,小剂量654-2穴位注射治疗支气管哮喘急性发作31例[J].2004, 25( 4) :349
[202]侯小藏,王淑华,斯奇康穴位注射治疗哮喘58例[J].四川中医, 2002, 20 (8):79
[203]路欣,汤建萍等,复方蛤青注射液穴位注射治疗支气管哮喘34例分析[J].实用中医内科杂志,2005,19(3):282
[204]虞金龙,穴位敷贴预防支气管哮喘的临床观察[J]. 2007,l26:6
[205]李丽,中药外敷配合内服治疗咳嗽变异性哮喘7A例[J].实用中医内科杂志,2005,19(1):66
[206]黄水清,谢雪华等.复方止喘膏外贴神阙穴治疗支气管哮喘疗效观察[J].中国误诊学杂志,2005.5(1):71
[207]张小平,内外合治小儿支气管哮喘的临床研究[J].中医外治杂志,2003, 12(6): 8-9
[208]姬晓兰,穴位综合疗法治疗哮喘312例临床观察[J].新疆中医药,2005, 23(4): 23-24
[209]宣丽华.穴位贴敷加穴位注射防治支气管哮喘的临床研究[J].中国针灸, 2002,22(7):441-442
[210]沈虹.穴位贴敷对支气管哮喘患者血浆SP和VIP含量的影响[J].河南中医, 2002,22(2):20
[211]李月梅.辨证贴药对于过敏性哮喘患者IL-5及ECP的影响[J].中国针灸, 2002,22(2):119-120
[212]梁春,伦新等穴位埋线治疗支气管哮喘疗效观察[J].辽宁中医杂志,2009, 36 (2):264
[213]张琳,穴位埋线对哮喘大鼠Th1/Th2的影响[J].贵阳中医学院学报, 2008, 5 (3):46
[214]周小鸿,陈立生,吕俊彪等,穴位十字形埋线治疗支气管哮喘56例疗效观察[J].新中医, 2007, 39 (8): 65
[215]杨培智.穴位植入疗法治疗慢性支气管哮喘的临床疗效观察[J].针灸临床杂志,2003,19(9):44-45
[216]自血穴位注射治疗儿童支气管哮喘26例[J].浙江中医杂志2007, 42 (7):419
[217]雷建华,刘金阁等,自血穴位注射治疗支气管哮喘的临床观察[J].河北中医2008, 30(4): 367
[218]孟胜喜,李文涛,张中成等.自血穴位注射治疗哮病42例临床分析[J].河南中医,1999,19(3):63
[219]李芝萍,拔火罐配合穴位贴敷治疗支气管哮喘疗效观察[J].河南中医,2007,7(7):59
[220]马嘉瑾,隆长泉等.针刺后拔罐配合TDP照射治疗支气管哮喘36例[J].浙江中医杂志,2006,41(8):476
[221]陈月琴,梅花针加艾灸治疗支气管哮喘临床观察[J].实用中医内科杂志,2008, 22( 12): 94
[222]杜善侠,吴延逊,崔联民等,梅花针加艾灸治疗哮喘120例[J].中国针灸, 2002, 22(4):221
[223]符文彬,陈秀华等,眼针控制哮喘急性发作的临床观察[J].上海针灸杂志,2002,21(5):20-21
[224]唐双胜,眼针治疗支气管哮喘26例临床观察[J].针炙临床杂志,1996,12( 10); 24
[225]李克刚,耳穴贴压治疗支气管哮喘58例[J].中国针灸,2000,(11):686
[226]邢剑秋,韩燕等,耳针从肝论治咳嗽性哮喘39例[J].江苏中医,2000, 21 (11):42
[227]王爱英,生物共振治疗仪治疗小儿哮喘200例效果观察[J].齐鲁护理杂志,2007, 13(11)
[228]蔡彦,陈文裕,陈创荣,揭西娜,余瑾等,纳子法电针治疗对哮喘模型豚鼠嗜酸性粒细胞凋亡的影响[J].广州中医药大学学报,2008, 25(2):124
[229]房翳恭,火针对哮喘患者IL-4、IFN-γ的影响及机制探讨[J].山东中医药大学学报,2006,30(4):304-305
[230]罗慧芳,小针刀加局封治疗重度哮喘300例临床分析[J].右江医学, 2001, 29(4):342-343
[231]冷钰玲,潘清蓉.磁圆针叩击法治疗哮喘64例临床观察[J].针灸临床杂志,2002,18(12):32-33
[232]华兴邦.大鼠穴位图谱的研制.实验动物与动物实验,1991;1:1
[233]吕国平,崔德健,郭英江等.介绍一种建立大鼠哮喘模型的实验方法[J].中华结核和呼吸杂志,1995,28(6):377-378
[234]RenziPM ,Olivenstein R,Martin JG,etal. Inflammatory Cell population in the airway and parenehyma after antigen challenge in rat.Am Revrespir Dis,1993,147:967
[235]申洪,免疫组织化学染色定量方法研究[J].中国组织化学与细胞化学杂志,1995,4(l):89292
[236]王妍,金先桥等,支气管哮喘实验模型的研究进展[J].国际呼吸科杂志,200626(1):70
[237]陈黎,吕祖铭.哮喘动物模型制作的进展[J].泸州医学院学报,2002,22(2):173-175
[238]吕国平,崔德健,郭英江.介绍一种大鼠哮喘模型的实验方法[J].中华结核和呼吸杂志1995,18:377
[239]Karol MH.Animal modeis of occupational asthma[J].Eur Respir J,1994,7( 3):555
[240]Elwood W, Lovall JO, Barnes PJ, et al.Characterization of allergen indu -ced bronchial hyperresponsiveness and airway inflammation in activity sensitized brown-norway rats[J].Allergy Clin Immunol, 1991, 88: 951
[241]刘传合,薛全福,陈育智等.支气管哮喘动物模型的研究状况[J].中华结核和呼吸杂志,2000,23(11):647
[242]Bianco A, Spiteri MA. A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma [J]. Monaldi Arch chest Dis, 1998; 53(1): 83
[243]Michel O, Kips J, Duchateau J, et al. Severity of asthma is related to endotoxin in house dust [J]. Am J Respir Crit CareMed, 1996; 154 (6Pt1): 1641
[244]CarrMJ, Spalding LJ, Goldie RG, et al. Distribution of immunoreactive endothelin in the lungs of mice during respiratory viral intection [J]. Eur Respir J, 1998;11(1):79
[245]HerzU, Ruckert R, WollenhauptK, et al. Airway exposure to bacterial supera -ntigen (SEB) induces lymphocyte-dependent airway inflammation assoc -iated with increased airway responsiveness-a model for non-allergic asthma [J]. Eur J Immunol, 1999; 29(3):1021
[246]张惠兰,张珍祥,徐永健等.用紫外线灭活的呼吸道合胞病毒复制小鼠哮喘动物模型[J].中国病理生理杂志,2002,18(12):1561-1563
[247]KumarRK, FosterPS.Modeling allergic asthma in mice pitfalls and opport -unities[J].Am J Respir Cell MolBio,2002;27(3):262-72
[248]Haczku A, Takeda K, Hamelmann, E, et al. CD23 exhibitsmegative regul -atory effects on allergc sensitization and airway hyperresponsiveness [J]. Am J Respir Critcore Med, 2000;161 (3PT1):952
[249]Nagase T, Dallaire MJ, Ludwing MS. Airway and tissre reponses during hyperpnae-inducedconstriction in guinea pigs,Am [J]. J Respir Crit Care Med, 1994; 149 (5): 1342
[250]Nagai H, IwamaT, Mori H, et al. Increase in respiratory resistance after exercise in conscious guinea pigs. As a model for exercise induced asthma [J]. Bilo Pharm Bull, 1995; 18(1):37
[251]王学诗.穴位注射治疗咳嗽变异性哮喘32例[J].上海针灸杂志,1998,17(1)∶15
[252]符文彬,陈秀华,陈全新等.眼针控制哮喘急性发作的临床观察[J].上海针灸杂志,2000,21(5)20
[253]黄万义.走罐配合指针治疗小儿哮喘30例[J].上海针灸杂志,2001,20(3)∶24
[254]吴广伟.自制挑割针刀治疗支气管哮喘143例[J].上海针灸杂志,1998, 17(5):17
[255]倪伟,于素霞,王宏长等.穴位敷贴疗法治疗寒型哮喘[J].上海针灸杂志,2001,20(3)∶10
[256]沈群.针刺听会穴治疗哮喘急性发作75例[J].上海针灸杂志,1997,16(4)∶16
[257]沈利华.伏天穴位注射卡介苗多糖核酸注射液对支气管哮喘患者免疫功能的影响[J].中医杂志,2000,41(6)∶343
[258]郭同经.穴位注射法[M].山东科学技术出版社,1983,24-73
[259]曹德寿,刘晓湘,巩永凤等.实验性支气管哮喘豚鼠肺和内脏感觉传入系统蛋白激酶C的表达及神经生长因子的调节作用[J].中华结核和呼吸杂志, 2005, 28 (8):525-529
[260]崔永斌,王京京,吴朝中等.从背俞穴与夹脊穴的关系论背俞功能带[J].中国针灸,2005,25(7):483-486
[261]王天俊等,埋针疗法的临床特点与适应证[J].上海针灸杂志.2007,26(10):37
[262]温木生.皮下针疗法治百病[M].北京:人民军医出版社,2003:15
[263]郑秀芹,方芳.皮下针治疗急性痛症46例[J].中国针灸,1998, 18(8):464
[264]刘宝华,孟宪典.皮内针治疗“肩周炎”100例观察[J].颈腰痛杂志, 1994,15(4):232
[265]何玲.论皮内针疗法的临床应用[J].上海针灸杂志,2003, 22(2):38
[266]仇裕丰.介绍一种无痛长效针法—体穴埋针法[J].针灸临床杂志, 2003, 19(1): 36
[267]刘俊红,张泽国.百会穴埋针配合艾灸治疗中气下陷30例[J].中国针灸, 1998, 18(4):203
[268]李光海.皮下埋针治疗面肌痉挛的疗效观察[J].针灸临床杂志, 2005, 21(8): 27
[269]陈龙,李文丽.膈俞穴埋针治疗膈肌痉挛65例[J].河北中医药学报, 1998, 13(2):24
[270]汪桐,经络实质的二重反射假说[J].皖南医学,1997,8(1):11
[271]槐瑞丽,牛丽静,管振龙等,孤束核的结构与功能[J].河北师范大学学报.2003,27(2):186
[272]HARRISON T A. Chorda tympani nerve stimulation evokes Fos expression in regionally limited neuron populations within the gustatory nucleus of the solitary tract [J]. Brain Res, 2001,904(1):54-66
[273]HECK W L, RENEHAN W E, SCHWEITZER L. Redistribution and increased specificity of GABA(B) receptors during development of the rostral nucleus of the solitary tract [J]. Int J Dev Neurosci,2001,19(5):503-515
[274]MACHADO B H, MAUAD H, CHIANCA J D A,et al. Autonomic processing of the cardiovascular reflexes in the nucleus tractus solitarii [J]. Braz J Med Biol Res, 1997, 30 (4): 533-543
[275]WASSERMAN A M, SAHIBZADA N, HERNANDEZ Y M,et al. Specific subnuclei of the nucleus tractus solitarius play a role in determining the duration of inspiration in the rat [J]. Brain Res, 2000,880:118-130
[276]BROUSSARD D L, ALTSCHULER S M. Central integration of swallow and airway-protective reflexes [J]. Am J Med, 2000, 108 Suppl 4a:62S-67S
[277]EMOND M, SCHWARTZ G J, MORAN T H. Meal-related stimuli differentially induce c-Fos activation in the nucleus of the solitary tract [J].Am J Physiol Regul Integr Comp Physiol, 2001,280(5):R 1 315-1327
[278]TANAKA K, MORITA H, SUWAKI H,et al. Effects of microinjection of kainic acid into the nucleus tractus solitarius on fluid and NaCl absorption across the jejunum [J].J Auton Nerv Syst,1994, 48(2):97-104
[279]MARTIN K, KONG T H, RENEHAN W,et al. Identification and function of brain stem neurons regulating rat ileal water absorption [J]. Am J Physiol, 1989, 257(2Pt1):G 266-273
[280]KREIS M E, MULLER M, ZITTEL T T,et al. Mediators of neuronal activation in the rat brainstem following intestinal anaphylaxis [J]. Neurosci Lett, 2000, 289(1): 45-48
[281]MORGAN M M, SOHN J H, LOHOF A M,et al. Characterization of stimu lation -produced analgesia from the nucleus tractus solitarius in the rat [J]. Brain Res,1989, 486(1):175-180
[282]LEWIS J W, BALDRIGHI G, AKIL H. A possible interface between autonomic function and pain control:opioid analgesia and the nucleus tractus soli tarius[J].Brain Res,1987,424(1):65-70
[283]管振龙,郎兵,丁玉强.胃肠道伤害性刺激引起大鼠孤束核与中脑导水管周围灰质神经元表达Fos[J].中国神经科学杂志,1998,14(4):199-204
[284]孟卓,吕国蔚.大鼠脊髓背角神经元与孤束核的电生理研究[J].科学通报,1990,4(7):292-295
[285]孟卓,吕国蔚.足三里-脊髓背角-孤束核的功能联系[J].中国科学,1992,35(9):393-399
[286]吴利平,李辉,李云庆等.大鼠延髓和脊髓背角的PKCr阳性神经元向孤束核投射[J].第四军医大学学报,2001,22(23):2171-2174
[287]陈译斌,王述菊,王亚文.损毁室旁核及孤束核对电针内关穴抗家兔心肌缺血作用的影响[J].中国中医急症, 2005, 14(8): 759
[288]张咏梅,张建福,陈幽婷等.胃缺血/再灌注损伤引起大鼠脑室旁核及孤束核c-fos表达[J].中国应用生理学杂志, 2004, 20(1): 20
[289]郭洪志,王蕾.延髓内脏带与内脏器官功能障碍关系的研究进展[J].中国脑血管病杂志, 2004, 1(12): 569
[290]AkimotoTF,Tamuara M, etal.Abrogation of bronchial eosinoPhilic inflammationand airway hyperreactivity in signal transudcers activator soft rnascription (STAT) 6-defieient mice.Jexp Med, 1998, 187(9):1537-1542
[291]Daniel Hebenstreit, Gerald Wirnsberger, Jutta Horejs-Hoeek, Albert Dusehl. Signaling Mechanisms, interaction partners,and target genes of STAT6.Cytokine Growth FR, 2006, 17(3):173-188
[292] Mattes J,Yang M,Mahalingam S,et al.Intrinsic defect in T cell production of interleukin(IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airway shyperreactivity in experimental asthma. JEM, 2002, 195: 1433-1444
[293]邓俊芳,谢强敏,邓杨梅等.致敏小鼠肺组织eotaxin和TNF-α的表达及药物的影响[J].浙江大学学报(医学版),2003,23(4):283
[294]Rankin SM,ConroyDM,W illiamsTJ. Eotaxin and eosin-ophil recruitment: implications for human disease [J].MolMedToday, 2000, 6(1):20-27
[295]张华,韩德民.嗜酸性粒细胞趋化因子eotaxin及其受体CCR3与呼吸道变应性炎症[J].新疆医科大学学报,2006,29(5):467-468
[296]陈强,细胞因子与支气管哮喘的研究进展[J].实用儿科临床杂志, 1999, 14: 174-175
[297]RyanJJ.Interleukin-4 and its receptor essential mediators of the alergic response [J]. J A llergy Clin Immunol 1997, 99: 1-5
[298]OrlyAA. IL-4 plays a dominant role in the differential development of The interleukin cell [J]. J Immunol 1992, 148: 3820
[299]DentAL, Hu LJ, PaulWE, et, al T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factorSTAT6 [J].ProcNat1 Acad SciUSA, 1998, 95: 13823
[300]OuyangWJ,LohnignM,GaoZG,etalSTAT6-independentGATA-3 autoactivation directs IL-4 independent Th2 develomentand commiment [J]. Immuity, 2000, 12: 27
[301]张罗,周炎,韩德民等.变应性鼻病研究进展(一):发病机制[J].耳鼻咽喉-头颈外科杂志,2003,10(5):316-320
[302]吴健,徐军,钟南山.BCG-5变应性哮喘TH1/TH2平衡[J].国外医学呼吸系统分册,2001,21(3):151-153
[303]Mauser PJ, Pitman A, Witt A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pigmodel of asthma. AmRev Respir Dis,1993, 148: 1623-1627
[304]Hogan SP, Matthaei KI, Young JM, et al. A novel T cell-regulated mecha -nism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol, 1998, 161:1501-1509
[305]王跃春、王子栋、何斯纯等.c-fos在阿尔茨海默病及血管性痴呆模型大鼠脑中的表达[J].中国临床康复,2003,7(28):3802-3
[306]柏志全,周丽丽,姚平等.电针对脑缺血再灌注大鼠海马fos蛋白的影响[J].中国临床康复, 2003.7(28):3804-5
[307]封亚平,章翔,武弋等.亚低温条件下局部脑神经元c-fos蛋白表达变化[J].中国临床康复, 2004, 8(10):1870-1
[308]方淑萍,戚好文等.哮喘神经机制的研究进展[J].国际呼吸杂志.2007,27(1):64
[309]肖剑,董榕,刘佳,刘伲娜等.下丘脑室旁核经迷走神经复合体对哮喘大鼠的神经调控研究[J].神经解剖学杂志.2007,23(3):299-304
[310]刘仁慧等,神经内分泌免疫调节失衡与支气管哮喘发病[J].江西中医药.2004; 35(258):62
[311]胡春梅,董榕,刘保森等.大鼠孤束核内H受体对哮喘发作时脑组织中Fos蛋白表达的影响[J].东南大学学报(医学版),2005; 24: 371-374
[312]Senba E, MatsunagaK, TohyamaM etal. Stess induced c-fos expression in the rat brain : Activation mechaism of sympathetic pathway. Brain ResBul,l 1993; 31: 329-344
[313]BarnesPJ. Neurogenic inflammation in the airways. Respir Physiol 2001; 125: 145-154
[314]郭同经.穴位注射法[M].济南:山东科学技术出版社,1993,24-73
[315]Hoyle GW Graham RM, Finkelstein JB et,al Hyperinnervation of the air -ways in transgenic mice over expressing nerve growth factor.Am J Respir Cell Mol Biol,1998,18:149-157
[316]KumarM,VermaNS,TinariS,etal.Sympathetichyperactivi-ty in patients of bronch -ial asthma. Indian J Physiol Pharmacol,2005,49:89-94
[317]Groneberg DA,Folkerts G,Peiser C,etal.Neuropeptide Y(NPY).Pulm PharmacolTher,2004,17:173-180
[318]Groneberg DA, Folkerts G, Peiser C, etal.Neuropeptide Y(NPY). Pulmphar-macol Ther,2004,17:173-180
[319]Tomaki M,Ichinose M, Miura M,et al.Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis[J]. Am J Respir Crit Care Med, 1995,151:613
[320]Maggl CA, Giachetti A, Dey RD, et al.Neuropeptides as regulators of airway function: vasoactive intestinal peptiede and the tachykinins[J]. Physiol Rev, 1995, 75:277
[321]Mukaiyama O, Morimoto K, Nosaka E, et al. Greater involvement of neurok -inins found in Guinea pig models of severe asthma compared with mild asthma.Int Arch Allergy Immunol,2004,134:263-272
[322]Palgan K, Dziedziczko A. Role of neurotrophin and neuropeptides in bronchial asthma.Pol Merkuriusz Lek,2004,16:101-103
[323]陈汉平,顾法隆等.关于腧穴功能研究的若干问题[J].上海针灸杂志, 1989, (1):1
[324]李明华,殷凯生,董竞成等.哮喘病药物治疗学[M].北京:人民卫生出版社,2001:128-135